Holdings
GSK plc
As of Jun 30, 2026, GSK plc reported 9 positions worth US$231M. Largest: Vir Biotechnology, Inc., Ideaya Biosciences, Inc. and Cytokinetics, Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vir Biotechnology, Inc. | 8.55M | US$87.1M | no change | Jun 30, 2026 |
| Ideaya Biosciences, Inc. | 1.33M | US$49.7M | no change | Jun 30, 2026 |
| Cytokinetics, Incorporated | 340K | US$29M | no change | Jun 30, 2026 |
| Lyell Immunopharma, Inc. | 1.51M | US$21.3M | no change | Jun 30, 2026 |
| Spero Therapeutics, Inc. | 9.19M | US$20.3M | no change | Jun 30, 2026 |
| Nkarta, Inc. | 3.15M | US$8.92M | no change | Jun 30, 2026 |
| Fulcrum Therapeutics, Inc. | 1.79M | US$6.54M | no change | Jun 30, 2026 |
| Cvrx, Inc. | 1.01M | US$5.18M | no change | Jun 30, 2026 |
| Regenxbio Inc. | 271K | US$3.25M | no change | Jun 30, 2026 |